• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Latest News

The Weekly Roundup: October 7-11
The Weekly Roundup: October 7-11

October 11th 2024

In case you missed it, we had news about benzene in benzoyl peroxide acne products tested at room temperature, the FDA's approved sNDA for 3 tubes of aminolevulinic acid hydrochloride, phase 2b trial data of zasocitinib, and more.

Tirbanibulin Demonstrates Efficacy for Actinic Keratosis in Larger Field Treatment
Tirbanibulin Demonstrates Efficacy for Actinic Keratosis in Larger Field Treatment

October 11th 2024

Safe and Effective: Upadacitinib Shows Promise in PN Treatment
Safe and Effective: Upadacitinib Shows Promise in PN Treatment

October 11th 2024

Disparities in Hidradenitis Suppurativa: A Closer Look at Skin of Color Populations
Disparities in Hidradenitis Suppurativa: A Closer Look at Skin of Color Populations

October 11th 2024

Fourth Ustekinumab Biosimilar, Otulfi, Approved in US
Fourth Ustekinumab Biosimilar, Otulfi, Approved in US

October 11th 2024

Navigating CSU Diagnosis: Best Practices
Meet the 2024 Quarterly Editor in Chiefs
Subscribe Now for Free - eNL
Explore Our Conference Coverage
Subscribe for Free - Print
Stay Informed!
Don't miss the latest in dermatology news
2

Conference Coverage

View All
Highly Prevalent, Scarcely Supported: Common Skin Issues Remain Underserved
Highly Prevalent, Scarcely Supported: Common Skin Issues Remain Underserved

October 10th 2024

Phase 2b Trial Reinforces Zasocitinib’s Safety Profile
Phase 2b Trial Reinforces Zasocitinib’s Safety Profile

October 8th 2024

Tralokinumab Shows Long-Term Efficacy for AD in Sensitive Areas
Tralokinumab Shows Long-Term Efficacy for AD in Sensitive Areas

October 7th 2024

Join Your Dermatology NP/PA Community at the Elevate Derm PA NP Conference
Join Your Dermatology NP/PA Community at the Elevate Derm PA NP Conference

October 7th 2024

Latest Videos

All News

© 2024 MJH Life Sciences

All rights reserved.